PROSTATE CANCER (ADENOCARCINOMA)
Clinical trials for PROSTATE CANCER (ADENOCARCINOMA) explained in plain language.
Never miss a new study
Get alerted when new PROSTATE CANCER (ADENOCARCINOMA) trials appear
Sign up with your email to follow new studies for PROSTATE CANCER (ADENOCARCINOMA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy targets advanced prostate cancer in early trial
Disease control Not yet recruitingThis early-phase study tests a new drug called LC-K76 combined with standard hormone therapy in 40 men with metastatic hormone-sensitive prostate cancer. The main goal is to check safety and see if the drug helps lower PSA levels. Participants will take the drug for 24 weeks and …
Matched conditions: PROSTATE CANCER (ADENOCARCINOMA)
Phase: EARLY_PHASE1 • Sponsor: Shanghai Changzheng Hospital • Aim: Disease control
Last updated May 17, 2026 02:03 UTC
-
New drug combo aims to stop prostate cancer relapse after surgery
Disease control Not yet recruitingThis study tests whether adding the drug rezvilutamide to standard hormone therapy can lower the chance of prostate cancer returning in high-risk patients who have just had their prostate removed. About 33 participants will take rezvilutamide daily plus hormone shots for up to 2 …
Matched conditions: PROSTATE CANCER (ADENOCARCINOMA)
Phase: NA • Sponsor: Fujian Medical University Union Hospital • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New program aims to protect cancer Patients' hearts during treatment
Disease control Not yet recruitingThis study tests a program called Primary Care Connect (PC2) for cancer survivors who also have heart-related conditions like high blood pressure, diabetes, or high cholesterol. The goal is to see if the program helps them stay connected to their primary care doctor and better ma…
Matched conditions: PROSTATE CANCER (ADENOCARCINOMA)
Phase: NA • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated May 12, 2026 13:42 UTC
-
New hope for Hard-to-Treat prostate cancer: targeted radiation plus chemo
Disease control Not yet recruitingThis early-phase study tests a combination of chemotherapy (docetaxel) and a targeted radioactive drug (177Lu-PSMA) in 18 men with advanced prostate cancer that has stopped responding to hormone therapy. The main goal is to find the safest dose of docetaxel when given with the ra…
Matched conditions: PROSTATE CANCER (ADENOCARCINOMA)
Phase: PHASE1 • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Disease control
Last updated May 11, 2026 20:48 UTC
-
Could surgery after meds tame tough prostate cancer?
Disease control Not yet recruitingThis study tests whether men with advanced prostate cancer that has spread to other parts of the body can benefit from having their prostate removed after initial drug therapy. Participants first receive 6 months of hormone-blocking drugs. Those whose scans show the cancer has qu…
Matched conditions: PROSTATE CANCER (ADENOCARCINOMA)
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated May 05, 2026 11:56 UTC
-
Smarter radiation: fewer sessions, fewer side effects for prostate cancer
Disease control Not yet recruitingThis study tests a personalized radiation approach for men whose prostate cancer has returned after surgery. Using PSMA PET scans, doctors will give higher radiation doses to areas with cancer and lower doses to healthy tissue. The goal is to reduce side effects while keeping tre…
Matched conditions: PROSTATE CANCER (ADENOCARCINOMA)
Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated May 04, 2026 16:18 UTC
-
Glow-in-the-Dark dye could spot prostate cancer cells during biopsy
Diagnosis Not yet recruitingThis early-stage trial tests a fluorescent dye called AS1986NS that may help doctors see prostate cancer cells during a biopsy. Ten men with suspected prostate cancer will receive a tiny dose of the dye before their standard biopsy. The main goal is to check if the dye is safe an…
Matched conditions: PROSTATE CANCER (ADENOCARCINOMA)
Phase: PHASE1, PHASE2 • Sponsor: Antelope Surgical Solutions, Inc • Aim: Diagnosis
Last updated May 06, 2026 16:03 UTC
-
New laser microscope could help surgeons save nerves during prostate cancer surgery
Diagnosis Not yet recruitingThis study tests a new tool called LaserSAFE that uses a special microscope to scan the prostate right after it is removed during surgery. The goal is to see if it can quickly find cancer cells at the edge of the prostate, which helps surgeons decide whether it is safe to spare n…
Matched conditions: PROSTATE CANCER (ADENOCARCINOMA)
Phase: NA • Sponsor: University College, London • Aim: Diagnosis
Last updated Apr 30, 2026 15:50 UTC
-
Prostate cancer Treatment's hidden toll: new study tracks sexual side effects
Symptom relief Not yet recruitingThis study follows 130 men with unfavorable intermediate-risk prostate cancer to see how combining stereotactic body radiation therapy (SBRT) with 6 months of hormone therapy impacts their sexual function. Researchers will measure erectile function before treatment and again at 2…
Matched conditions: PROSTATE CANCER (ADENOCARCINOMA)
Sponsor: CancerCare Manitoba • Aim: Symptom relief
Last updated May 17, 2026 02:18 UTC